Billionaire Profile

Global Rank

#2110

Image: Public domain | via Wikimedia Commons

Dong Fan

CEO, Jafron Biomedical

Real-Time Net Worth

$1.4B

As of December 2025

Age

Source

Medical devices

Industry

healthcare

Citizenship

Biography

Dong Fan is a prominent figure in China's medical device industry. He is the chairman of Jafron Biomedical, a company specializing in hemoadsorption technology. His career began with a degree in trade economics from Shanghai University of Finance and Economics. However, Dong chose to pioneer a new frontier in medical technology, specifically in the areas of blood purification and hemoadsorption. Dong Fan's technological contributions have been recognized globally, with his technology currently in use across more than 8,000 hospitals in 90 countries and has nearly 5 million clinical applications each year. Forbes has recognized Dong Fan as a billionaire, with his primary source of wealth coming from medical devices.

Wealth Over Time

Portfolio Holdings

Jafron Biomedical

In-Depth Profile

Early Life

Dong Fan's journey began with a degree in trade economics from Shanghai University of Finance and Economics. Initially, he didn't follow a conventional career path, choosing instead to delve into the world of medical technology.

Rise to Success

Dong Fan is the chairman of Jafron Biomedical, a company specializing in hemoadsorption technology, which was founded in 1989. He saw the potential of ion exchange resin technology, which was originally used for purifying heavy water in nuclear fuel production. Teaming up with Professor Yu Yaoting from Nankai University, they repurposed this technology for blood purification. This led to the creation of Jafron's Hemoadsorption technology, which is now widely used to treat chronic and critical illnesses. Dong Fan's efforts have been recognized globally, with his technology currently in use across more than 8,000 hospitals in 90 countries, with nearly 5 million clinical applications each year.

Key Business Strategies

Jafron's commitment to research has yielded a new generation of adsorption technology products, now widely used across eight major medical fields, including poisoning, critical illness, kidney disease, liver disease, and autoimmune disorders. As of now, Jafron boasts six major categories of hemoadsorption cartridges and holds 345 patents.

Philanthropy

In 2021, Dong Fan donated 6.2 million RMB to the Zhuhai Jianfan Sunshine Medical Foundation.

Career Milestones

1989

Founded Jafron Biomedical

Dong Fan founded Jafron Biomedical (originally Zhuhai Lizhu Medical Biomaterial) in 1989.

1999

Developed Hemoadsorption Cartridge

Dong Fan and his team at Jafron developed the world's first resin hemoadsorption cartridge.

2016

Jafron Biomedical IPO

Jafron Biomedical went public on the Shenzhen Stock Exchange.

Philanthropy & Social Impact

Medical

Zhuhai Jianfan Sunshine Medical Foundation

$0.91B

Donation to the Zhuhai Jianfan Sunshine Medical Foundation in 2021.